The production cost of Levetiracetam, an anticonvulsant used to treat epilepsy, is influenced by raw material sourcing, synthesis complexity, purification processes, and regulatory compliance. The manufacturing process involves multi-step organic synthesis, requiring high-purity intermediates, solvents, and catalysts, which significantly impact costs. Additional expenses include labor, energy consumption, equipment maintenance, and adherence to Good Manufacturing Practices (GMP) to ensure pharmaceutical-grade quality. Compliance with FDA, EMA, and other regulatory bodies further adds to production expenses. Market demand, supplier availability, and advancements in process optimization play a crucial role in determining the overall production cost of Levetiracetam.